Volume 103, Issue 1 pp. 160-168
ORIGINAL ARTICLE - CLINICAL SCIENCE

Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation

Israel M. Barbash MD

Corresponding Author

Israel M. Barbash MD

Interventional Cardiology Unit, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Correspondence Israel M. Barbash, MD, Faculty of Medicine, Tel-Aviv University, Interventional Cardiology Unit, Leviev Heart Center, Sheba Medical Center, Ramat Gan, Israel.

Email: [email protected]

Search for more papers by this author
Yishay Wasserstrum MD

Yishay Wasserstrum MD

Interventional Cardiology Unit, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for more papers by this author
Magdalena Erlebach MD

Magdalena Erlebach MD

Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany

Search for more papers by this author
Victor Guetta MD

Victor Guetta MD

Interventional Cardiology Unit, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for more papers by this author
Johannes Ziegelmüller MD

Johannes Ziegelmüller MD

Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany

Search for more papers by this author
Amit Segev MD

Amit Segev MD

Interventional Cardiology Unit, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for more papers by this author
Paul Fefer MD

Paul Fefer MD

Interventional Cardiology Unit, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for more papers by this author
Elad Maor MD

Elad Maor MD

Interventional Cardiology Unit, Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel

Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for more papers by this author
Rüdiger Lange MD

Rüdiger Lange MD

Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany

Search for more papers by this author
Hendrik Ruge MD

Hendrik Ruge MD

Department of Cardiovascular Surgery, German Heart Center Munich, Technische Universität München, Munich, Germany

Search for more papers by this author
First published: 07 December 2023
Citations: 2

Abstract

Background

New vascular closure devices (VCD) are being introduced for achieving hemostasis after transcatheter aortic valve implantation (TAVI). However, no safety or efficacy data have been published compared to other contemporary VCD.

Aim

To compare the safety and efficacy of suture-based Perclose Prostyle as compared to plug-based MANTA device.

Methods

A total of 408 consecutive TAVI patients from two high volume TAVI centers were included in the present study. Patients were grouped according to VCD: Prostyle versus MANTA. Propensity score matching (PSM) and multivariable analysis were utilized to compare clinical endpoints between the two groups. The primary endpoint was any vascular complication (VC) according to VARC-3 criteria.

Results

After PSM, a total of 264 patients were analyzed, of them 132 in each group. Overall baseline characteristics of the two groups were comparable. Primary end-point was similar between MANTA as compared to Prostyle (16.7% vs. 15.3% respectively, p = 0.888). The main driver for VC among MANTA group were minor vascular complications (15.2%). Conversely, minor and major VC contributed equally to the primary endpoint among Prostyle group (7.6%) (p = 0.013). No outcome predictors were identified in multivariate analysis.

Conclusions

VCD for transfemoral TAVI using the new-generation Prostyle device or the MANTA device achieved comparable VARC-3 VC rates.

CONFLICT OF INTEREST STATEMENT

The authors declare no conflicts of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.